Kathleen Burgess1, Katherine M Atkinson2,3, Jacqueline Westeinde1, Natasha Crowcroft4,5, Shelley L Deeks4,5, Kumanan Wilson2,6,7. 1. Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, CanadaK1Y 4E9. 2. Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada K1Y 4E9. 3. Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden. 4. Public Health Ontario, Toronto, ON, Canada. 5. Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. 6. Department of Medicine, University of Ottawa, Ottawa, Canada. 7. Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada.
Abstract
Background: Barriers and facilitators of mobile app adoption are not known. This study examined usage of a new Pan-Canadian immunization app to identify factors that contributed to usage. Methods: Women in their third trimester of pregnancy or had given birth in the previous 3 months were recruited from a hospital obstetrical unit. Fifty-five participants were instructed to download the ImmunizeCA app. After at least 6 months, 10 interviews were conducted, transcribed and coded. Themes identified were compared with aggregate ImmunizeCA usage data (n = 74 212 users). Results: Facilitators included features that address logistical challenges, improved convenience and information access. Barriers included absence of system integration. Concerns regarding the privacy and security of personal health information were not an inhibitor as long as best practices are followed. Google Analytics data on usage supported qualitative findings. Conclusion: Future studies should evaluate the quantitative impact of factors we identified on app uptake and usage. Subsequent mobile app studies may benefit from the use of analytic data as they were found to be effective in helping to validate qualitative data derived from interviews with study participants.
Background: Barriers and facilitators of mobile app adoption are not known. This study examined usage of a new Pan-Canadian immunization app to identify factors that contributed to usage. Methods:Women in their third trimester of pregnancy or had given birth in the previous 3 months were recruited from a hospital obstetrical unit. Fifty-five participants were instructed to download the ImmunizeCA app. After at least 6 months, 10 interviews were conducted, transcribed and coded. Themes identified were compared with aggregate ImmunizeCA usage data (n = 74 212 users). Results: Facilitators included features that address logistical challenges, improved convenience and information access. Barriers included absence of system integration. Concerns regarding the privacy and security of personal health information were not an inhibitor as long as best practices are followed. Google Analytics data on usage supported qualitative findings. Conclusion: Future studies should evaluate the quantitative impact of factors we identified on app uptake and usage. Subsequent mobile app studies may benefit from the use of analytic data as they were found to be effective in helping to validate qualitative data derived from interviews with study participants.
Authors: Katherine M Atkinson; Robin Ducharme; Jacqueline Westeinde; Sarah E Wilson; Shelley L Deeks; Dante Pascali; Kumanan Wilson Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452
Authors: Russell J McCulloh; Sarah D Fouquet; Joshua Herigon; Eric A Biondi; Brandan Kennedy; Ellen Kerns; Adrienne DePorre; Jessica L Markham; Y Raymond Chan; Krista Nelson; Jason G Newland Journal: J Am Med Inform Assoc Date: 2018-09-01 Impact factor: 4.497
Authors: Caroline de Cock; Michelle van Velthoven; Madison Milne-Ives; Mary Mooney; Edward Meinert Journal: JMIR Mhealth Uhealth Date: 2020-05-18 Impact factor: 4.773